COVID-19 Vaccine Contender CureVac Links Up with Bayer
A German company that is in the advanced stages of producing a vaccine against COVID-19 is linking up with pharmaceutical giant Bayer to help develop and distribute the product.
CureVac, based in the German city of Tuebingen, said last month that it expects first results by the end of March from its phase 3 clinical study of the mRNA-based vaccine candidate called CVnCoV.
www.manufacturing.net/home/news/21220171/covid19-vaccine-contender-curevac-links-up-with-bayer
https://www.curevac.com/en/covid-19/